Cargando…

The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP

The poor prognosis of HNSCC is partly due to treatment resistance. The SMAC mimetic Xevinapant is a promising new approach to targeted cancer therapy. Xevinapant inhibits cIAP1/2 and XIAP, leading to apoptosis, necroptosis and inhibition of prosurvival signaling. Combining Xevinapant with IR could i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Julia, Hildebrand, Laura S., Kuhlmann, Lukas, Fietkau, Rainer, Distel, Luitpold V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297233/
https://www.ncbi.nlm.nih.gov/pubmed/37371123
http://dx.doi.org/10.3390/cells12121653
_version_ 1785063834922254336
author Fleischmann, Julia
Hildebrand, Laura S.
Kuhlmann, Lukas
Fietkau, Rainer
Distel, Luitpold V.
author_facet Fleischmann, Julia
Hildebrand, Laura S.
Kuhlmann, Lukas
Fietkau, Rainer
Distel, Luitpold V.
author_sort Fleischmann, Julia
collection PubMed
description The poor prognosis of HNSCC is partly due to treatment resistance. The SMAC mimetic Xevinapant is a promising new approach to targeted cancer therapy. Xevinapant inhibits cIAP1/2 and XIAP, leading to apoptosis, necroptosis and inhibition of prosurvival signaling. Combining Xevinapant with IR could improve therapeutic potential. The effect of Xevinapant in combination with IR on HNSCC and healthy tissue cells was investigated. Cell growth, cell death, clonogenic survival and DNA double-strand breaks (DSBs) were studied, and intracellular cIAP1 and XIAP levels were evaluated. Xevinapant had cytostatic and cytotoxic, as well as radiosensitizing, effects on the malignant cells, while healthy tissue cells were less affected. Apoptotic and necrotic cell death was particularly affected, but the increase in residual DSBs and the reduced survival implied an additional effect of Xevinapant on DNA damage repair and other cell inactivation mechanisms. cIAP1 and XIAP levels varied for each cell line and were affected by Xevinapant and IR treatment. There was an association between higher IAP levels and increased cell death. Xevinapant appears to be a potent new drug for HNSCC therapy, especially in combination with IR. IAP levels could be an indicator for impaired DNA damage repair and increased susceptibility to cellular stress.
format Online
Article
Text
id pubmed-10297233
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102972332023-06-28 The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP Fleischmann, Julia Hildebrand, Laura S. Kuhlmann, Lukas Fietkau, Rainer Distel, Luitpold V. Cells Article The poor prognosis of HNSCC is partly due to treatment resistance. The SMAC mimetic Xevinapant is a promising new approach to targeted cancer therapy. Xevinapant inhibits cIAP1/2 and XIAP, leading to apoptosis, necroptosis and inhibition of prosurvival signaling. Combining Xevinapant with IR could improve therapeutic potential. The effect of Xevinapant in combination with IR on HNSCC and healthy tissue cells was investigated. Cell growth, cell death, clonogenic survival and DNA double-strand breaks (DSBs) were studied, and intracellular cIAP1 and XIAP levels were evaluated. Xevinapant had cytostatic and cytotoxic, as well as radiosensitizing, effects on the malignant cells, while healthy tissue cells were less affected. Apoptotic and necrotic cell death was particularly affected, but the increase in residual DSBs and the reduced survival implied an additional effect of Xevinapant on DNA damage repair and other cell inactivation mechanisms. cIAP1 and XIAP levels varied for each cell line and were affected by Xevinapant and IR treatment. There was an association between higher IAP levels and increased cell death. Xevinapant appears to be a potent new drug for HNSCC therapy, especially in combination with IR. IAP levels could be an indicator for impaired DNA damage repair and increased susceptibility to cellular stress. MDPI 2023-06-17 /pmc/articles/PMC10297233/ /pubmed/37371123 http://dx.doi.org/10.3390/cells12121653 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fleischmann, Julia
Hildebrand, Laura S.
Kuhlmann, Lukas
Fietkau, Rainer
Distel, Luitpold V.
The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title_full The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title_fullStr The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title_full_unstemmed The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title_short The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
title_sort effect of xevinapant combined with ionizing radiation on hnscc and normal tissue cells and the impact of xevinapant on its targeted proteins ciap1 and xiap
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297233/
https://www.ncbi.nlm.nih.gov/pubmed/37371123
http://dx.doi.org/10.3390/cells12121653
work_keys_str_mv AT fleischmannjulia theeffectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT hildebrandlauras theeffectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT kuhlmannlukas theeffectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT fietkaurainer theeffectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT distelluitpoldv theeffectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT fleischmannjulia effectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT hildebrandlauras effectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT kuhlmannlukas effectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT fietkaurainer effectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap
AT distelluitpoldv effectofxevinapantcombinedwithionizingradiationonhnsccandnormaltissuecellsandtheimpactofxevinapantonitstargetedproteinsciap1andxiap